Biotech

NewLimit's $435M Series C: Inside the Longevity Biotech Bet

**TL;DR:** NewLimit raised $435 million in Series C funding on June 2, 2026, at a $3.1 billion valuation. Founders Fund led the round. Brian Armstrong (Coinbase CEO) co-founded the company in 2021 and